You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Catumaxomab

Showing 1 - 18 of 18
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Urinary Bladder Tumors Trial in München (Catumaxomab)

Recruiting
  • Urinary Bladder Neoplasms
  • Catumaxomab
  • München, Germany
    Urologie Planegg
Apr 4, 2022

Bladder Cancer Trial in Guangzhou (Catumaxomab)

Not yet recruiting
  • Bladder Cancer
  • Catumaxomab
  • Guangzhou, Guangdong, China
  • +1 more
Mar 16, 2021

Stomach Tumors Trial in China, Korea, Republic of, Taiwan (Catumaxomab, The treatment of investigator choice)

Recruiting
  • Stomach Neoplasms
  • Catumaxomab
  • The treatment of investigator choice
  • Beijing, Beijing, China
  • +12 more
May 10, 2021

Malignant Ascites Trial in United States (catumaxomab)

Completed
Has Results
  • Malignant Ascites
  • catumaxomab
  • Tucson, Arizona
  • +17 more
Sep 18, 2018

Patients With Gastric Peritoneal Carcinomatosis Trial in Villejuif (Catumaxomab 100µg, Catumaxomab 140µg)

Terminated
  • Patients With Gastric Peritoneal Carcinomatosis
  • Catumaxomab 100µg
  • Catumaxomab 140µg
  • Villejuif, Val de Marne, France
    Institut Gustave Roussy
Jan 25, 2017

Ovarian Cancer Trial in Spain (Catumaxomab)

Completed
  • Ovarian Cancer
  • Catumaxomab
  • Girona, Barcelona, Spain
  • +16 more
Aug 9, 2016

Patients Treated With Bevacizumab Intraperitoneal for Treatment

Completed
  • Refractory Malignant Ascites
  • No intervention. Descriptive study
  • Paris, Ile-de-France, France
    Groupe Hospitalier Paris Saint Joseph
Aug 10, 2018

Recurrent Epithelial Ovarian Cancer Trial in Berlin (Catumaxomab)

Completed
  • Recurrent Epithelial Ovarian Cancer
  • Catumaxomab
  • Berlin, Germany
    Charité Campus Virchow-Klinikum
Feb 17, 2015

Gastric Cancer, Gastric Adenocarcinoma Trial in Worldwide (Catumaxomab, catumaxomab)

Completed
  • Gastric Cancer
  • Gastric Adenocarcinoma
  • Catumaxomab
  • catumaxomab
  • Innsbruck, Austria
  • +3 more
Dec 3, 2013

Epithelial Cancer Patients Trial in Wien, Copenhagen, Barcelona (catumaxomab)

Terminated
  • Epithelial Cancer Patients
  • catumaxomab
  • Wien, Austria
  • +2 more
Jul 1, 2013

Malignant Ascites, Gastrointestinal Cancers Trial in Germany (Bevacizumab, Placebo)

Completed
  • Malignant Ascites
  • Gastrointestinal Cancers
  • Ludwigsburg, Baden-Württemberg, Germany
  • +25 more
Apr 10, 2015

Ovarian Cancer, Epithelial Ovarian Cancer Trial in Innsbruck, Berlin (Catumaxomab)

Completed
  • Ovarian Cancer
  • Epithelial Ovarian Cancer
  • Catumaxomab
  • Innsbruck, Austria
  • +1 more
Oct 2, 2012

Cancer, Tumors, Carcinoma Trial in Several (Catumaxomab, Prednisolone)

Completed
  • Cancer
  • +3 more
  • Several, France
  • +3 more
Oct 2, 2012

Malignant Ascites Due to Epithelial Carcinoma Trial in Berlin (catumaxomab)

Completed
  • Malignant Ascites Due to Epithelial Carcinoma
  • catumaxomab
  • Berlin, Germany
    Charité Campus Virchow Clinic
Oct 2, 2012

Ovarian Cancer Trial in United States (catumaxomab)

Completed
Has Results
  • Ovarian Cancer
  • catumaxomab
  • Tucson, Arizona
  • +11 more
Jul 16, 2012

EpCam Positive Tumor (e.g.Ovarian, Gastric, Colon, Breast), Malignant Ascites Trial (Catumaxomab (Removab), paracentesis)

Completed
  • EpCam Positive Tumor (e.g.Ovarian, Gastric, Colon, Breast)
  • Malignant Ascites
  • Catumaxomab (Removab)
  • paracentesis
  • (no location specified)
Feb 4, 2009

Gastric Cancer, Gastric Adenocarcinoma Trial in Cologne (catumaxomab)

Completed
  • Gastric Cancer
  • Gastric Adenocarcinoma
  • catumaxomab
  • Cologne, Germany
    Hospital of Cologne-Merheim, Surgical Department
Oct 25, 2007

Ovarian Cancer, Fallopian Tube Tumors, Peritoneal Tumors Trial in Marburg (anti-EpCAM x anti-CD3 (removab))

Completed
  • Ovarian Cancer
  • +2 more
  • anti-EpCAM x anti-CD3 (removab)
  • Marburg, Germany
    Dept. of Gynecology, University of Marburg
Nov 7, 2006